VA Launches Psilocybin Trial For Veterans With Treatment-Resistant Depression
Longtime Slashdot reader sbinning shares a press release: The U.S. Department of Veterans Affairs announced the launch of a new clinical trial to evaluate the effectiveness and safety of psilocybin to treat major depression in Veterans, including those with concurrent PTSD. The new trial comes after a recent executive order on "Accelerating Medical Treatments for Serious Mental Illness," which…
The U.S. Department of Veterans Affairs has initiated a clinical trial to assess the efficacy and safety of psilocybin in treating severe depression among Veterans, including those who grapple with concurrent post-traumatic stress disorder (PTSD). This trial follows an executive order aimed at boosting involvement in clinical trials and expediting innovative research models and drug approvals for psychedelic substances.
The randomized, controlled study will recruit Veterans diagnosed with treatment-resistant major depressive disorder, either with or without PTSD. It will compare the outcomes between two different doses of psilocybin. The research will also evaluate the participants' depression levels before and after treatment, the tolerability of any side effects, and their overall patient-reported depression.
Beyond this trial, the VA is already involved in twenty active clinical trials focusing on psychedelic therapies for mental health issues. All VA research, including studies on psychedelics, is conducted under stringent safety protocols and in strict adherence to federal guidelines.
Written by urgent.news from Slashdot's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
